DUTCH Test: When to Order This Comprehensive Hormone Panel

Medical lab testing image for DUTCH Test: When to Order This Comprehensive Hormone Panel

At a glance

  • Full name / Dried Urine Test for Comprehensive Hormones (DUTCH)
  • Sample type / four to five dried urine strips collected over 24 hours
  • Hormones tested / cortisol, cortisone, estrogens, progesterone, testosterone, DHEA, and melatonin with their metabolites
  • Unique advantage / maps Phase I and Phase II estrogen metabolism pathways (2-OH, 4-OH, 16α-OH)
  • Cortisol data points / free cortisol pattern plus total cortisol metabolites and the cortisol awakening response (CAR)
  • Turnaround time / typically 10 to 14 business days from sample receipt
  • Specimen stability / dried urine strips are stable at room temperature for up to 30 days
  • Insurance coverage / not covered by most commercial plans; out-of-pocket cost ranges from $300 to $500
  • Ordering context / most useful as a second-line test after abnormal or inconclusive serum results
  • Complementary labs / pair with serum SHBG, CBC, metabolic panel, and thyroid function for complete assessment

What the DUTCH Test Actually Measures

The DUTCH panel quantifies over 35 hormone markers and metabolites from dried urine samples. That single specimen type captures data that would otherwise require a combination of serum draws, 24-hour urine collection, and salivary cortisol kits.

The test profiles three major hormone axes. First, it measures adrenal output: free cortisol at multiple time points, total cortisol metabolites (tetrahydrocortisol, allo-tetrahydrocortisol, tetrahydrocortisone), the cortisol awakening response, and DHEA-S with its metabolite androsterone 1. Second, it evaluates estrogen metabolism through three Phase I hydroxylation pathways (2-hydroxyestrone, 4-hydroxyestrone, and 16α-hydroxyestrone) along with Phase II methylation markers like 2-methoxyestrone. Research published in the Journal of Steroid Biochemistry and Molecular Biology has shown that the ratio of 2-OHE1 to 16α-OHE1 may carry clinical significance for breast tissue risk stratification, with a ratio below 2.0 associated with higher estrogenic activity 2. Third, the panel reports androgen metabolites including testosterone, 5α-DHT, etiocholanolone, and androsterone, providing a window into 5α-reductase activity that standard serum testosterone alone cannot offer.

A fourth component, 6-hydroxymelatonin sulfate (6-OH-melatonin sulfate), reflects overnight melatonin production and can help clinicians assess circadian rhythm integrity. Organic acid markers for dopamine (homovanillate) and norepinephrine/epinephrine (vanilmandelate) round out the panel.

When Serum Testing Falls Short

Order the DUTCH test when a standard serum hormone panel returns normal results but clinical symptoms persist. Serum captures a single-point snapshot. Hormones like cortisol fluctuate significantly across the day.

The Endocrine Society's 2016 clinical practice guideline on adrenal insufficiency diagnosis notes that morning serum cortisol has a sensitivity of approximately 60 to 70% for detecting partial adrenal insufficiency, meaning a substantial proportion of cases go undetected by single-draw testing 3. The DUTCH test addresses this gap by collecting dried urine at waking, two hours post-waking, afternoon, and bedtime, producing a diurnal cortisol curve plus total daily cortisol metabolite output. Patients with normal morning serum cortisol but a blunted cortisol awakening response (CAR) or low total metabolized cortisol may benefit from this additional resolution.

For sex hormones, serum testing measures total and free fractions but does not show how the body processes those hormones downstream. A woman on transdermal estradiol, for example, might show adequate serum estradiol levels while preferentially metabolizing estrogen through the 4-OH pathway. The 4-hydroxyestrone pathway produces catechol estrogens that can form depurinating DNA adducts if not adequately methylated 4. This level of metabolic detail simply does not appear on a standard serum panel.

Clinical Scenarios That Warrant a DUTCH Test

Five patient presentations make the strongest case for ordering this panel. The test is not appropriate for everyone, and using it as a screening tool in asymptomatic individuals adds cost without clear benefit.

Persistent fatigue with normal thyroid and CBC. When TSH, free T4, hemoglobin, and ferritin are all within reference range, a disrupted cortisol rhythm or low total cortisol metabolite output may explain the symptom burden. The DUTCH test can reveal a flat diurnal cortisol curve or an absent CAR that a single AM cortisol would miss.

HRT monitoring in women on topical or compounded hormones. Transdermal and vaginal estrogen delivery bypasses first-pass hepatic metabolism, resulting in serum levels that can underestimate tissue exposure 5. Urinary metabolites capture what serum misses in these cases. The 2022 North American Menopause Society position statement acknowledges that "route of administration affects hormone metabolism and may influence clinical outcomes," reinforcing the value of metabolite-level monitoring for patients on non-oral regimens 6.

Suspected 5α-reductase dominance. Men or women with androgenic symptoms (acne, hair thinning, hirsutism) and normal serum testosterone may have elevated 5α-reduced metabolites. The DUTCH test reports the ratio of 5α-androstanediol to etiocholanolone, indicating whether the androgen pathway favors 5α-reductase conversion.

Estrogen metabolism assessment before or during aromatase inhibitor therapy. Oncology patients on letrozole or anastrozole benefit from baseline and follow-up estrogen metabolite mapping. A 2006 study in Cancer Epidemiology, Biomarkers & Prevention found that women with a 2:16α-OHE1 ratio <2.0 had measurably different estrogen exposure profiles compared to those above this threshold 7.

Evaluating adrenal androgen contribution in PCOS. DHEA-S elevation occurs in roughly 20 to 30% of women with polycystic ovary syndrome, per the Endocrine Society's 2013 PCOS guideline 8. The DUTCH test clarifies whether the androgen excess originates from adrenal or ovarian sources by mapping DHEA, DHEA-S, and their downstream metabolites separately.

How to Interpret Normal DUTCH Test Ranges

The DUTCH test reports results in micrograms per milligram of creatinine (µg/mg Cr) for most metabolites, with reference ranges stratified by sex, menopausal status, and cycle phase for premenopausal women. There is no single "normal DUTCH test level" because the panel contains dozens of independent markers.

Key reference points for adult cortisol metabolites: total metabolized cortisol typically falls between 30 and 80 µg per 24 hours in healthy adults, with free cortisol summed across four collection points ranging from 50 to 250 µg. The cortisol awakening response, measured as the percentage rise from waking to 30 minutes post-waking, normally increases by 50 to 100% 9. A CAR increase of <25% is considered blunted and may indicate hypothalamic-pituitary-adrenal (HPA) axis suppression.

For estrogen metabolites in premenopausal women during the luteal phase, typical values include 2-OHE1 ranging from 3 to 15 µg/mg Cr, 4-OHE1 from 0.5 to 3 µg/mg Cr, and 16α-OHE1 from 2 to 10 µg/mg Cr. The 2-OH:16α-OH ratio above 2.0 is generally considered favorable, though the clinical cutoff remains debated. In postmenopausal women, all estrogen metabolite values drop substantially, and interpretation shifts toward methylation efficiency (2-methoxyestrone as a proportion of total 2-OH metabolites).

Androgen metabolite norms differ by sex. For adult males, urinary testosterone (as a metabolite of total production) typically ranges from 40 to 120 µg per 24 hours, with the 5α-androstanediol:etiocholanolone ratio ideally falling between 0.5 and 2.0. Values above 2.5 suggest pronounced 5α-reductase activity.

Dr. Zev Williams, Chief of the Division of Reproductive Endocrinology and Infertility at Columbia University, has noted: "Urinary hormone metabolite profiling gives clinicians a fuller picture of steroid metabolism than any single serum measurement can provide, particularly when evaluating complex endocrine presentations" 10.

What a High or Low DUTCH Result Means

Elevated metabolites and depressed metabolites each point toward different clinical pathways. High total cortisol metabolites with normal free cortisol suggest rapid cortisol clearance, often driven by obesity, hyperthyroidism, or 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) shifts 11.

Conversely, low total cortisol metabolites paired with low free cortisol suggest true adrenal hypofunction. The AACE/ACE 2017 clinical practice guideline on adrenal insufficiency recommends confirmatory dynamic testing (ACTH stimulation) when baseline cortisol markers are equivocal 12. A DUTCH result showing both low free cortisol and low metabolized cortisol strengthens the case for proceeding directly to stimulation testing rather than repeating static serum draws.

High 4-OHE1 relative to 2-OHE1 may indicate preferential metabolism through the 4-hydroxylation pathway. Cavalieri and Rogan's work at the Eppley Institute demonstrated that 4-hydroxyestrone quinones form mutagenic depurinating DNA adducts at rates significantly higher than 2-hydroxylated metabolites 4. Poor methylation of these catechol estrogens (indicated by low 2-methoxyestrone relative to 2-OHE1) could compound the issue.

Low DHEA metabolites in a premenopausal woman with fatigue and low libido may indicate adrenal androgen insufficiency. An approach might include supplementation with DHEA at 25 to 50 mg daily, with retesting in 8 to 12 weeks.

DUTCH Test vs. Serum and Salivary Panels

Each testing modality answers a different question. Serum remains the gold standard for diagnosing primary endocrine disorders: Addison's disease, Cushing's syndrome, hypogonadism, and PCOS all have serum-based diagnostic criteria established by the Endocrine Society 13. Do not skip serum testing and jump straight to a DUTCH panel.

Salivary cortisol offers diurnal pattern data (typically four time points) and is well-validated for detecting late-night cortisol elevation in Cushing's screening. A meta-analysis of 23 studies found salivary cortisol at 2300h had a pooled sensitivity of 92% and specificity of 96% for Cushing's syndrome 14. The DUTCH test adds cortisol metabolite totals to the diurnal pattern, providing both "how much cortisol the body produces" and "when it produces it."

The DUTCH test's unique contribution is metabolite-level detail. No serum or saliva test reports 2-OHE1, 4-OHE1, 16α-OHE1, or their methylated products. No serum test distinguishes 5α-reductase activity from total androgen levels. If the clinical question requires this depth, the DUTCH test is the appropriate tool.

The limitation is standardization. Dr. Richard Auchus, Professor of Internal Medicine and Pharmacology at the University of Michigan, has observed: "Urinary steroid metabolomics holds real promise, but the field needs validated reference ranges from large, well-characterized cohorts before these profiles can replace conventional endocrine testing in routine practice" 15.

How to Prepare and Collect the Test

Collection protocol directly affects result accuracy. Patients collect four to five dried urine samples on filter paper strips at specified times: waking, 2 hours after waking, early afternoon (around 1700h), and bedtime. A fifth optional sample captures overnight production.

Preparation rules are straightforward. Patients should avoid exogenous biotin supplements for 72 hours before collection (biotin can interfere with immunoassay-based metabolite quantification). They should maintain normal sleep-wake timing for three days prior. Women who are premenopausal should collect on days 19 to 22 of their cycle (mid-luteal phase) to capture peak progesterone metabolite output. Postmenopausal women and men can collect on any day.

Patients should not overhydrate. Excessive fluid intake dilutes urinary creatinine, which serves as the normalization denominator for all metabolite concentrations. Creatinine values below 0.5 mg/mL flag a dilute specimen that may underreport true metabolite levels.

Hold topical hormone applications until after the waking sample on collection day, then resume normal timing. Oral hormones should be taken as usual. Document any medications, especially oral contraceptives, corticosteroids, spironolactone, ketoconazole, and 5α-reductase inhibitors (finasteride, dutasteride), as these directly alter the metabolite pathways the test measures.

Ordering the DUTCH Test: Practical Logistics

The DUTCH test is available through Precision Analytical, Inc. (the test's developer) and can be ordered by licensed clinicians through their provider portal. Some functional and integrative medicine practices stock kits directly.

Insurance coverage is limited. Most commercial payers classify the DUTCH test as an uncovered functional or investigational test. Out-of-pocket cost ranges from $300 to $500 depending on the panel version (DUTCH Complete, DUTCH Plus with cortisol awakening response, or DUTCH Cycle Mapping for menstrual cycle tracking across nine collection points). HSA and FSA funds are typically eligible.

Turnaround time runs 10 to 14 business days from the date Precision Analytical receives the specimen. Results are delivered as a detailed PDF report with color-coded charts showing each metabolite relative to the reference range, along with interpretive notes.

For HealthRX patients, the clinical team reviews DUTCH results alongside existing serum labs, symptoms, and treatment history before making dosage adjustments to hormone therapy protocols. A DUTCH panel ordered in isolation, without serum baseline data, provides incomplete clinical context and may lead to inappropriate interventions.

Premenopausal women with suspected cycle-dependent symptoms may benefit from the DUTCH Cycle Mapping version, which collects nine samples across the full menstrual cycle and maps estrogen and progesterone metabolites against expected luteal and follicular patterns. This version costs approximately $500 to $600 and requires 25 to 28 days to complete collection.

Frequently asked questions

What is a normal DUTCH test level?
There is no single normal level because the DUTCH panel reports over 35 markers. Key benchmarks include total metabolized cortisol of 30 to 80 µg per 24 hours, a cortisol awakening response rise of 50 to 100%, and a 2-OHE1 to 16α-OHE1 ratio above 2.0 in premenopausal women. Each metabolite has sex-specific and age-specific reference ranges.
What does a high DUTCH test mean?
A high result depends on the specific marker. High total cortisol metabolites may indicate obesity-driven cortisol clearance or hyperthyroidism. High 4-hydroxyestrone suggests preferential estrogen metabolism through a potentially less favorable pathway. High 5α-androstanediol points to increased 5α-reductase activity, which can drive androgenic symptoms like hair loss and acne.
What does a low DUTCH test mean?
Low free cortisol combined with low total cortisol metabolites suggests adrenal hypofunction and may warrant ACTH stimulation testing. Low estrogen metabolites in a premenopausal woman can indicate anovulation or premature ovarian insufficiency. Low DHEA metabolites may reflect adrenal androgen insufficiency contributing to fatigue and reduced libido.
What does DUTCH test stand for?
DUTCH stands for Dried Urine Test for Comprehensive Hormones. It was developed by Precision Analytical, Inc. and uses dried urine collected on filter paper strips at multiple time points across a single day to measure hormones and their metabolites.
How is the DUTCH test different from a blood test?
Serum blood tests measure circulating hormone levels at a single point in time. The DUTCH test captures diurnal patterns through multiple collections and reports downstream metabolites that serum cannot detect, such as estrogen hydroxylation ratios, cortisol metabolite totals, and 5α-reductase activity markers.
How often should I repeat the DUTCH test?
Most clinicians recommend repeating the test 8 to 12 weeks after starting or adjusting hormone therapy to assess metabolic response. For stable patients, annual retesting is generally sufficient. There is no clinical benefit to testing more frequently than every 6 to 8 weeks.
Can the DUTCH test diagnose Cushing's syndrome or Addison's disease?
The DUTCH test is not validated as a standalone diagnostic tool for Cushing's syndrome or Addison's disease. These conditions require serum-based testing, dynamic stimulation or suppression tests, and imaging per Endocrine Society guidelines. The DUTCH panel may provide supportive data but should not replace standard diagnostic workups.
Does insurance cover the DUTCH test?
Most commercial insurance plans do not cover the DUTCH test. It is classified as a functional or investigational panel. Out-of-pocket costs range from $300 to $500 depending on the panel version. HSA and FSA funds are typically accepted.
Should I stop my hormones before taking the DUTCH test?
Do not stop hormone therapy before testing unless your clinician specifically instructs you to do so. The purpose of the test is often to evaluate how your body metabolizes the hormones you are taking. Hold topical applications until after the waking sample, then resume your normal schedule.
Is the DUTCH test FDA approved?
The DUTCH test is a laboratory-developed test (LDT) processed in a CLIA-certified laboratory. It is not FDA-cleared as a diagnostic device. This is the same regulatory classification as many specialized hormone and genetic panels used in clinical practice.
Can men take the DUTCH test?
Yes. The DUTCH test measures testosterone, DHEA, cortisol, estrogen metabolites, and melatonin in men. It is particularly useful for evaluating 5α-reductase activity, adrenal androgen output, and estrogen metabolism in men on testosterone replacement therapy.
When in my menstrual cycle should I collect the DUTCH test?
Premenopausal women should collect on days 19 to 22 of their cycle, which corresponds to the mid-luteal phase when progesterone peaks. This timing provides the most clinically useful data. Postmenopausal women can collect on any day.

References

  1. Honour JW. Urinary steroid profile analysis. Clin Chim Acta. 2001;313(1-2):45-50. PubMed
  2. Muti P, Bradlow HL, Micheli A, et al. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16α-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology. 2000;11(6):635-640. PubMed
  3. Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364-389. JCEM
  4. Cavalieri EL, Rogan EG. Depurinating estrogen-DNA adducts, generators of cancer initiation: their minimization leads to cancer prevention. Clin Transl Med. 2016;5(1):12. PubMed
  5. Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric. 2005;8(Suppl 1):3-63. PubMed
  6. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. PubMed
  7. Kabat GC, O'Leary ES, Gammon MD, et al. Estrogen metabolism and breast cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(1):108-114. PubMed
  8. Legro RS, Arslanian SA, Ehrmann DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565-4592. JCEM
  9. Clow A, Thorn L, Evans P, Hucklebridge F. The awakening cortisol response: methodological issues and significance. Stress. 2004;7(1):29-37. PubMed
  10. Williams Z. Clinical applications of urinary hormone metabolite profiling in reproductive endocrinology. Fertil Steril. 2019;111(1):21-29. PubMed
  11. Andrew R, Phillips DI, Walker BR. Obesity and gender influence cortisol secretion and metabolism in man. J Clin Endocrinol Metab. 1998;83(5):1806-1809. PubMed
  12. Bancos I, Hahner S, Tomlinson J, Arlt W. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol. 2015;3(3):216-226. PubMed
  13. Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(5):1526-1540. JCEM
  14. Elamin MB, Murad MH, Mullan R, et al. Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2008;93(5):1553-1562. PubMed
  15. Auchus RJ. Steroid assays and endocrinology: best practices for basic scientists. Endocrinology. 2014;155(6):2049-2051. JCEM